Mucocutaneous leishmaniasis and AIDS: case report

dc.date.accessioned2022-10-09T17:42:33Z
dc.date.available2022-10-09T17:42:33Z
dc.date.created2022-10-09T17:42:33Z
dc.date.issued1993
dc.identifierhttps://hdl.handle.net/20.500.12866/12279
dc.identifierhttps://doi.org/10.1016/0035-9203(93)90484-8
dc.description.abstractIn Perd tegumentary leishmaniases are endemic, more than 5000 new cases per year being reported by the Ministry of Health, although the estimated real incidence is three times as great, and human immunodeficiency virus (HIV) infections and the reported incidence of the acquired immune deficiency syndrome (AIDS) are increasing. The more frequently reported infectious diseases associated with AIDS patients in Perd are diarrhoea due to coccidia, extrapulmonary tuberculosis, cerebral toxoplasmosis, and cryptococcal meningitis...
dc.languageeng
dc.publisherOxford University Press
dc.relationTransactions of the Royal Society of Tropical Medicine and Hygiene
dc.relation1878-3503
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectAdult
dc.subjectMale
dc.subjectRecurrence
dc.subjectHuman
dc.subjectperu
dc.subjectpriority journal
dc.subjectskin leishmaniasis
dc.subjectacquired immune deficiency syndrome
dc.subjectAIDS-Related Opportunistic Infections
dc.subjectallopurinol
dc.subjectantiprotozoal agent
dc.subjectCase Report
dc.subjectHuman immunodeficiency virus
dc.subjectLeishmaniasis, Mucocutaneous
dc.subjectmeglumine antimonate
dc.subjectmucosa
dc.subjectpyrazolopyrimidine derivative
dc.subjecttuberculosis
dc.titleMucocutaneous leishmaniasis and AIDS: case report
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución